Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

Photon Health Secures $16M in Series A Funding to Modernize Prescription Infrastructure

Healthcare loves to celebrate innovation, but the prescription layer has been quietly running on delays, dead ends, and patchwork systems, where patients wait, providers chase, and “modern systems” still lean on workflows that feel older than they should, and Photon Health stepped into that tension without trying to dress it up, they went straight at it.

Now Photon Health just pulled in $16M in Series A funding, led by Healthier Capital with Notation Capital, Flare Capital Partners, and Evidenced stepping back into the ring, bringing real fuel to a company that has been building something most people didn’t realize was broken this badly in the first place, and credit where it’s due because Otto Sipe, CEO, saw the gap early, and alongside Co-Founders Sam Kotlove and Michael Rado, the original idea was simple but dangerous if you’re entrenched in the old system, give the prescription back to the patient, not metaphorically but literally.

Photon’s model lets clinicians send prescriptions directly to patients, who can then choose their pharmacy based on price, inventory, and timing, no guesswork, no blind routing, just actual choice, and it sounds obvious until you realize how long that option didn’t exist, and while the founding bench set the tone, the operating engine matters, with Sophie Maarleveld, COO, and Stu Libby, CRO, helping translate that vision into something that scales inside real health systems, not just pitch decks and product demos.

This is where the business lesson creeps in if you’re paying attention, because Photon didn’t win by being louder, they went deeper into infrastructure most founders avoid since it’s complex, regulated, and not exactly cocktail conversation material, but infrastructure is where leverage lives, build the rails and everyone else ends up riding your train whether they planned to or not, and the timing isn’t accidental either, with integrations like Amazon Pharmacy and athenahealth threading Photon into the existing ecosystem, turning friction into flow and moving the company from tool to default, and that word matters because the endgame isn’t just better prescribing, it’s becoming the invisible layer that makes modern prescribing feel obvious in hindsight, the kind of obvious that makes you wonder how we tolerated anything else for so long.